Nephroprotective and nitric oxide scavenging activity of tubers of momordica tuberosa in rats

Avicenna Journal of Medical Biotechnology

Volumn 3, Issue 2, 2011, Pages 87-93

  Kumar, Promod ^a   Devala Rao, G ^b   Lakshmayya, ^c   Ramachandra Setty, S ^d  

^a V L COLLEGE OF PHARMACY   (India)

^b KVSR SIDDHARTHA COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^c GRD (PG) Institute of Management and Technology   (India)

^d Government College of Pharmacy   (India)

Author keywords

Blood urea nitrogen; Cisplatin; Cucurbitaceae; Kidney failure; Lipid peroxidation; Nitric oxide

Indexed keywords

ALCOHOL; CISPLATIN; CREATININE; ENDOLIPIDE; GENTAMICIN; GLUTATHIONE; MOMORDICA TUBEROSA EXTRACT; NITRIC OXIDE; PARACETAMOL; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; FEMALE; LD 50; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; MOMORDICA TUBEROSA; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; TISSUE LEVEL; TREATMENT DURATION; UREA BLOOD LEVEL;

CUCURBITACEAE; MOMORDICA; RATTUS; RATTUS NORVEGICUS; TUBEROSA;

EID: 79960101988     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barry MB, Floyd CR. The Kidney (Vol I). Philadelphia: W.B. Saunders; 2000.
2. Helms RA, Quan DJ, Herfindal ET, Gourley DR. Textbook of Therapeutic: Drug and Disease Management. 7th ed. USA: Lippincott Williams & Wilkins; 2000.
3. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. Edinburgh: Churchill Living Stone; 2003.
4. Munson PL, Mueller RA, Breese GR. Principles of Pharmacology: Basic Concepts and Clinical Applications. New York: Chapman and Hall; 1996.
5. Banerjee AK, Akhbari Shad MHA, Roy SK. Urinary Stones, Diet and Folk Medicine. In: Agarwal BV, Munshi KN (eds). Facets of Co-ordination Chemistry. New Jersey: World Scientific Publishing; 1993,216-222.
6. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. New Delhi: Bishen Singh Mahendra Pal Singh; 1991.
7. Kameswararao B, Kesavulu MM, Apparao C. Evaluation of antidiabetic effects of Momordica cymbalaria fruit in alloxan diabetic rats. Fitoterapia 2003;74(1-2):7-13.
8. Koneri R, Balaraman R, Saraswati CD. Antiovulatory and abortifacient potential of the ethanolic extract of roots of Momordica cymbalaria Fenzl in rats. Indian J Pharmacol 2006;38(2):111-114.
9. Parvati S, Kumar VJ. Studies on chemical composition and utilization of wild edible vegetable Athalakkai (Momordica tuberosa). Plant Foods Hum Nutr 2002;57(3-4):215-222.
10. Kumar P, Devala Rao G, Lakshmayya S, Setty R. Antioxidant and hepatoprotective activity of tubers of Momordica tuberosa Cogn. against CCl4 induced liver injury in rats. Indian J Exp Biol 2008;46 (7):510-513.
11. Kokate CK. Practical Pharmacognosy. 1st ed. New Delhi: Vallabh Prakashan; 1996.
12. th ed. Pune: Nirali Prakashan; 2006.
13. Susanta Kumar M, Chakraborty G, Gupta M, Mazumder UK. In vitro antioxidant activity of Dispyros malabarica Kostel bark. Indian J Exp Biol 2006;44:39-44.
14. Corcostegui R, Labeaga L, Arteche JK, Orjales A. Protective effect of hidrosmin against cisplatin induced acute nephrotoxicity in rats. Pharm Pharmacol Commun 1998;4(9):465-467.
15. Shirwaikar A, Malini S, Kumari SC. Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Indian J Exp Biol 2003;41(1):58-62.
16. Tietz N. Fundamentals of Clinical Chemistry. Philadelphia: W.B. Saunders; 1968.
17. Tiftany TO, Jansen J, Burtis CA, Overton JB, Scott CD. Enzymatic kinetic rate and end-point analyses of substrate by use of a GeMSAEC fast analyzer. Clin Chem 1972;18:829-840.
18. Davidson I, Henry JB. Todd-Sanford Clinical Diagnosis and Management by Laboratory Method. 15th ed. Philadelphia: WB Saunders; 1974.
19. Vijay KK, Naidu MUR, Shifow AA, Ratnakar KS. Probucol protects against gentamicin induced nephrotoxicity in rats. Indian J Pharmacol 2000;32:108- 113.
20. Chattopadhyay RR. Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: Part II. J Ethnopharmacol 2003;89(2-3):217- 219.
21. Khandkar MA, Parmar DV, Das M, Katyare SS. Is activation of lysosomal enzymes responsible for paracetamol induced hepatotoxicity and nephrotoxicity? J Pharm Pharmacol 1996;48(4):437-440.
22. Abraham P. Oxidative stress in paracetamol induced pathogenesis: (I) renal damage. Indian J Biochem Biophy 2005;42(1):59-62.
23. Aykac G, Uysal M, Yalcin AS, Kocak-Toker N, Sivas A, Oz H. The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicol 1985;36(1):71-76.
24. Yoshiki Y, Kudou S, Okubo K. Relationship between chemical structures and biological activities of triterpenoid saponins from soybean. Biosci Biotech Biochem 1998;62(12):2291-2299.
25. San Martin R, Briones R. Industrial uses and sustainable supply of Quillaja saponaria (Rosaceae) saponins. Econ Bot 1999;53(3):302-311.
26. Thompson LU. Potential health benefits and problems associated with anti-nutrients in foods. Food Res Int 1993;26:131-149.
27. Ridout CL, Price KR, Dupont MS, Parker ML, Fenwick GR. Quinoa saponins-analysis and preliminary investigations into the effects of reduction by processing. J Sci Food Agric 1991;54(2):165-176.
28. Gurfinkel DM, Rao AV. Soya saponins: The relationship between chemical structure and colon anticarcinogenic activity. Nutr Cancer 2003;47(1): 24-33.
29. Kerwin SM. Soya saponins and the anticancer effects of soybeans and soy-based foods. Curr Med Chem Anticancer Agents 2004;4(3):263-272.
30. Oakenfull D. Soy proteins, saponins and plasma cholesterol. J Nutr 2001;131(11):2971-2972.
31. Matsuura H. Saponins in garlic as modifiers of the risk of cardiovascular disease. J Nutr 2001;131(3): 1000s-1005s.